Why the study?
Heart valve diseases remain poorly diagnosed, detected at delayed stages, and subject to regional inequalities in diagnostic and treatment technologies despite advances in pathophysiology and mini-invasive correction.
Highlights the necessity of a multidisciplinary 'valve cardiac team' to address delayed diagnosis and inequalities in the care of patients with acquired heart valve disease.
May support valve teams for complex cases; leaves open prospective outcome validation.
Despite advances in research of heart valve disease pathophysiology and active introduction of miniinvasive correction of this disease, heart valve diseases are still poorly diagnosed pathology. These diseases are detected in delayed stages, and there is still inequality in diagnostic and treatment technologies in different regions of the world and our country. In this review, we analyzed epidemiological data on various heart valve diseases, modern phenotype of these patients and factors associated with changes of phenotype. The main positions and limitations in organizing the medical care for these patients are presented. A particular attention is focused on importance of “valve cardiac team” making decisions on management in complex and controversial cases, as well as in comorbid patients with heart valve disease.
No takes yet. Share an insight, caveat, or question.
Барбараш et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: